BACKGROUND: Vascular disease (including myocardial infarction and peripheral artery
disease) has been proposed as a less well-validated risk factor for stroke in patients with …

BACKGROUND AND METHODS: The CHA2DS2-VASc score has been newly proposed for
stratifying patients with nonvalvular atrial fibrillation (AF) according to the risk of ischemic …

Background: Atrial fibrillation is associated with increased but variable risk of stroke. Our aim
was to validate the recently developed biomarker-based ABC (age, biomarkers [high …

Background Stroke risk in atrial fibrillation (AF) is often assessed at initial presentation, and
risk stratification performed as a 'one off'. In validation studies of risk prediction, baseline …

Stroke prevention is the cornerstone of the management of atrial fibrillation (AF), and
effective stroke prevention means oral anticoagulation (OAC), irrespective of symptoms or …

Many of the risk factors for stroke in atrial fibrillation (AF) are also important risk factors for
bleeding. We tested the hypothesis that the CHADS 2 and CHA 2 DS 2-VASc scores (used …

Atrial fibrillation (AF) patients are widely heterogeneous in terms of ischaemic stroke risk,
and several risk stratification schemes have been developed. We performed a prospective …

Background: Patients with atrial fibrillation (AF) have a higher risk of fatal complications (eg,
stroke). This investigation was performed as an observational retrospective cohort study …

Aims The impact of some risk factors for stroke and bleeding, and the value of stroke and
bleeding risk scores, in atrial fibrillation (AF), has been debated, as clinical trial cohorts have …

Decision making with regard to thromboprophylaxis should be based upon the absolute
risks of stroke/thromboembolism and bleeding and the net clinical benefit for a given patient …